Trials / Conditions / KRAS G12C Lung Cancer
KRAS G12C Lung Cancer
4 registered clinical trials studyying KRAS G12C Lung Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-III NCT07472478 | Guangdong Provincial People's Hospital | Phase 2 |
| Recruiting | A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed NCT06793215 | Hoffmann-La Roche | Phase 3 |
| Not Yet Recruiting | A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combina NCT06936644 | Shanghai Chest Hospital | Phase 2 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Pre NCT06497556 | Hoffmann-La Roche | Phase 3 |